Edan Instruments, Inc. (SHE:300206)

Market Cap	8.41B +30.4%
Revenue (ttm)	2.09B +15.7%
Net Income	345.60M +83.2%
EPS	0.60 +83.1%
Shares Out	579.66M
PE Ratio	24.32
Forward PE	n/a
Dividend	0.31 (2.10%)
Ex-Dividend Date	Apr 30, 2026

Volume	3,490,600
Average Volume	9,920,278
Open	14.98
Previous Close	14.50
Day's Range	14.27 - 14.98
52-Week Range	11.10 - 16.80
Beta	0.63
RSI	45.92
Earnings Date	Aug 21, 2026

About Edan Instruments

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, telemetry and IT products; and obstetrics, pelvic floor rehabilitation, and gynecology products. It also provides ultrasound systems that include cart-based ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,475
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300206

Financial Performance

In 2025, Edan Instruments's revenue was 2.00 billion, an increase of 8.97% compared to the previous year's 1.83 billion. Earnings were 305.64 million, an increase of 88.54%.